Skip to main content

Clinical Trial Results


Dr. C. Michael Gibson and Dr. Serge Korjian Discuss: CSL112 (Apolipoprotein A-I) Infusions And Cardiovascular Outcomes In Patients With Acute Myocardial Infarction (ApoA-I Event Reducing In Ischemic Syndromes II (AEGIS-II) Trial): Primary Trial Results

Loader Loading…
EAD Logo Taking too long?

Reload Reload document
| Open Open in new tab

Download [2.51 MB]

Disclosures: TBD